J&J Creates R&D Center with Tianjin Cancer Hospital

Johnson & Johnson Pharmaceutical Research Group will join Tianjin Medical University Cancer Hospital to build a Joint R&D Center in Oncology, which will be housed at the Tianjin Cancer Hospital. The goal is to establish a center that meets international standards of research. J&J had previously formed a cancer biomarker R&D project with Tianjin Cancer Hospital. More details... Stock Symbol: (NYSE: JNJ)